Page 1

Magid Abou-Gharbia, PhD, FRSC Associate Dean for Research Professor & Director Moulder Center for Drug Discovery Research (CDDR) 3307 North Broad Street Philadelphia, PA 19140

Phone 215-707-4949 Fax 215-707-4701 Email Web

May 8, 2012 Subject: Letter of support as Project’s consultant & scientific consultant Dear Mohsen Afona, This letter is in support of your research project entitled, "Transdermal delivery of the Antidiabetic Drug Glimepride: A novel Approach to Improve Percutaneous Management of Diabetes within the Saudi Society” which proposes the enhancement of the availability of Glimepride in transdermal delivery to avoid associated side effects of orally administered Drug. It is with pleasure that accept to serve as project’s consultant and scientific advisor. In this project, our Drug Discovery Center and Biopharmaceutics group at the School of Pharmacy at Temple University will be happy to provide needed support and to play a crucial role in facilitating achieving project’s objectives. I am excited about participating and contributing in your research project and I believe that having safe and effective transdermal delivery of antidiabetic drugs will have a significant impact on diabetes treatment. We look forward to working with you to improve the lives of diabetic patients. Sincerely Yours,

Magid Abou-Gharbia, Ph.D. Associate Dean for Research Director Moulder center

Prof. Dr. Abu-Gharbia  
Prof. Dr. Abu-Gharbia  

Letter of Support